Key Details
Price
$3.15Last Dividend
$0.05TTM Dividend Yield
3.18%Annual ROE
-4.68%Beta
1.59Events Calendar
Next earnings date:
Feb 20, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 13, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jun 17, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Although the revenue and EPS for Hudson Pacific (HPP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Hudson Pacific Properties (HPP) came out with quarterly funds from operations (FFO) of $0.10 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to FFO of $0.18 per share a year ago.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in the discovery and development of engineered B Cell Medicines (BCMs), today announced key milestones alongside a new round of funding as its lead program, BE-101 for Hemophilia B, enters the clinic, and its second development candidate for Hypophosphatasia is unveiled. Both programs are built on Be Bio's powerful and efficient BCM platform, which utilizes gene editing to engineer B cells to produce sus.
Hudson Pacific Properties (HPP) came out with quarterly funds from operations (FFO) of $0.17 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.24 per share a year ago.
Investors need to pay close attention to Hudson Pacific (HPP) stock based on the movements in the options market lately.
Although the financial results of Hudson Pacific (HPP) for the quarter ending in March 2024 provide an overview of the company's performance, it may be beneficial to analyze how certain key metrics stack up against Wall Street projections and figures from the same period last year.
Hudson Pacific Properties has reinstated its suspended quarterly cash dividend. The REIT conducted $1 billion in asset sales in 2023 as higher office vacancies continue to pressure FFO. The leases for a third of HPP's office rent base come up for renewal over the next two years, with rents set to drop dramatically.
Hudson Pacific missed FFO estimates in Q4 amid a bevy of industry headwinds. The company also issued light forward FFO guidance.
Hudson Pacific Properties, Inc. (HPP) Q4 2023 Earnings Call Transcript
While the top- and bottom-line numbers for Hudson Pacific (HPP) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FAQ
- What is the ticker symbol for Hudson Pacific Properties?
- Does Hudson Pacific Properties pay dividends?
- What sector is Hudson Pacific Properties in?
- What industry is Hudson Pacific Properties in?
- What country is Hudson Pacific Properties based in?
- When did Hudson Pacific Properties go public?
- Is Hudson Pacific Properties in the S&P 500?
- Is Hudson Pacific Properties in the NASDAQ 100?
- Is Hudson Pacific Properties in the Dow Jones?
- When was Hudson Pacific Properties's last earnings report?
- When does Hudson Pacific Properties report earnings?
- Should I buy Hudson Pacific Properties stock now?